Europe—not US—first to authorize Moderna’s combo mRNA flu-COVID vaccine

Moderna’s mRNA-based combination vaccine against both flu and COVID-19 has gotten the green light in Europe—but it continues ...

Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate

Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat. CAMBRIDGE, MA / ACC ...
Hosted on MSN

CureVac sues Moderna over mRNA patent claims tied to Spikevax

CureVac has filed a lawsuit in Delaware federal court accusing Moderna of infringing eight U.S. patents related to mRNA stabilization technology used in its COVID-19 vaccine Spikevax. The case ...

Moderna starts late-stage trial for bird flu vaccine

Moderna stock gains as the company begins dosing in a Phase 3 trial designed to evaluate its messenger RNA-based bird flu ...